DAPSONE, 50mg, tab.

STD DORADAPS5T-

Valid Article

Article is intended to be used with children (<12 years) ONLY.
6.2.4 - Antileprosy medicines
Classification of the medicines in groups and subgroups according to their therapeutic use. The classification used by MSF is based on the WHO Model List of Essential Medicines.
J04BA02
Anatomical Therapeutic Chemical Classification according to WHOCC
The order of this product needs to be justified and is only acceptable under certain conditions.
Thermosensitive codes are defined for storage and transportation temperature requirements of the products.
OC subscriptions: included in supply or field order tools (e.g. UniField)
SC subscriptions: included in supply or field tools
OC validations: approved for procurement and use by an OC for international or local orders specifying context and activity in Medical Standard Lists (MSL)

This combination does not exist.

Add article to list

   

Add Kit To Wishlist

   

DAPSONE

Therapeutic Action

Sulfone antibacterial

Indications

Prophylaxis of toxoplasmosis and pneumocystosis, in combination with pyrimethamine and folinic acid

Treatment of pneumocystosis, in combination with trimethoprim

Paucibacillary and multibacillary leprosy, in combination with rifampicin and clofazimine

Some restricted information has been hidden. Sign in to see this information

Instructions for use

The 50 mg tablet is intended for paediatric use.

Storage

Below 25ºC - Protect from humidity